Streetbeat News

Regulatory

CSE:XSF

XSHLF

XS Financial Inc. has secured a $15 million line of credit to fund expansion projects in the cannabis sector. The company plans to use the loan proceeds and cash on hand to fund additional CAPEX and equipment leases with new and existing customers. The news comes as the number of banks and credit unions working with cannabis companies is at a record high, and ahead of the Senate Banking Committee's vote on cannabis banking reform.

Portfolio Pulse from Jelena Martinovic

September 19, 2023 | 1:26 pm

NCNC

Noco-Noco Inc has filed for an offering of up to 33 million ordinary shares by a selling security holder, according to a SEC filing.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:26 pm

NVO

Novo Nordisk (NVO) has partnered with Aspen Pharmacare to produce human insulin in South Africa for export to African nations. The insulin will be supplied to health authorities and NGOs through a tender system with a maximum price of $3 per vial. The production is expected to reach 16 million insulin vials next year, equivalent to the yearly consumption of 1.1 million people. By 2026, this number will increase to 4.1 million people living with diabetes across Africa. Recently, the FDA reported quality control issues at Novo Nordisk's Clayton, North Carolina plant.

Portfolio Pulse from Vandana Singh

September 19, 2023 | 1:24 pm

IMMX

Immix Biopharma has announced the successful completion of its 2nd CAR-T NXC-201 engineering batch at its U.S. manufacturing site. This is a significant step in the planned U.S. expansion of the company's ongoing Phase 1b/2a NEXICART-1 study of its novel BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201. The company believes that NXC-201's observed zero neurotoxicity and favorable tolerability profile could enable expansion into earlier lines of therapy and out-patient NXC-201 dosing.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:24 pm

SPY

U.S. President Biden has stated that depleting the Strategic Petroleum Reserve is an option being considered. This move could potentially affect the oil market and related stocks.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:22 pm

CBRE

The Securities and Exchange Commission (SEC) has charged CBRE Group Inc. with violating the whistleblower protection rule. The details of the violation were not provided.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:21 pm

GSK

PFE

The European Commission has approved ViiV Healthcare's Apretude, a drug for HIV prevention. ViiV Healthcare is majority owned by GSK plc, with Pfizer Inc and Shionogi as shareholders. The drug reduces the number of doses needed for effective HIV prevention from 365 daily pills to as few as six injections per year. It has demonstrated superior efficacy to daily oral emtricitabine/tenofovir disoproxil fumarate in reducing the risk of HIV acquisition in clinical trials.

Portfolio Pulse from Vandana Singh

September 19, 2023 | 1:20 pm

BGNE

NVS

BeiGene Ltd has announced it will regain rights to develop, manufacture, and commercialize its cancer drug, Tevimbra, from Novartis AG. The European Commission has approved Tevimbra as a monotherapy for adults with certain types of cancer, and the FDA has accepted the biologics license application for the drug, with a target action date in the second half of 2024. BeiGene's shares are up 0.14% premarket.

Portfolio Pulse from Vandana Singh

September 19, 2023 | 1:18 pm

RVNC

Revance Therapeutics Inc has estimated total non-cash impairment charges from goodwill and other assets to be between $80M-$100M. The company anticipates completion of activities, including workforce reduction, by March 31, 2024, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:15 pm

DATS

Trading of DatChat shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:14 pm